# NeuroVision Imaging

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurovision-imaging

- Industry: Software
- Headquarters: Sacramento, US
- Website: www.neurovision.com
- Total disclosed funding: $11M
- Latest round: Series C (May 2, 2018)
- Investors on record: 5

## About

Founded in 2010 and based in California, US, NeuroVision Imaging, Inc. operates as a retinal imaging platform that diagnoses Alzheimer’s disease. The company was founded by its CEO, Steven R. Verdooner, and Keith Black. In May 2018, NeuroVision Imaging, LLC raised USD 11.2 million in Series C financing led by Wildcat Capital Management, Johnson & Johnson Innovation, SBI Investment, SP Global, and Whittier Ventures.

NeuroVision Imaging provides neurology diagnostics and managed telehealth services. The firm’s product line includes BrainHealth.net, a telehealth platform that offers evidence-based interventions to support individuals with Alzheimer's disease or other cognitive impairments; and Afina Retinal Imaging, which is cloud-based AI software that uses retinal imaging (taking pictures of the retina) to identify signs of Alzheimer's disease and Cerebral Amyloid Angiopathy (CAA). The company collaborates with health systems, national testing labs, and pharma companies to provide diagnostic biomarkers and digital therapeutic services.

## Funding rounds

- Series C, May 2, 2018, $11M — Johnson & Johnson Innovation, SBI Investment, Whittier Ventures, Wildcat Capital Management, VSP Global

## Investors

- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series C
- SBI Investment (https://capitalatlas.ai/funds/sbi-investment) — Series C
- Whittier Ventures — Series C
- Wildcat Capital Management — Series C
- VSP Global — Series C